This company listing is no longer active
OSAP.Q Stock Overview
Operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
ProSomnus, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.014 |
| 52 Week High | US$1.61 |
| 52 Week Low | US$0.004 |
| Beta | 0.17 |
| 1 Month Change | 172.00% |
| 3 Month Change | -63.24% |
| 1 Year Change | -99.03% |
| 3 Year Change | -99.86% |
| 5 Year Change | n/a |
| Change since IPO | -99.86% |
Recent News & Updates
Shareholder Returns
| OSAP.Q | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -9.3% | -4.8% | -3.7% |
| 1Y | -99.0% | 2.4% | 6.9% |
Return vs Industry: OSAP.Q underperformed the US Medical Equipment industry which returned -0.7% over the past year.
Return vs Market: OSAP.Q underperformed the US Market which returned 12.4% over the past year.
Price Volatility
| OSAP.Q volatility | |
|---|---|
| OSAP.Q Average Weekly Movement | 81.9% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: OSAP.Q's share price has been volatile over the past 3 months.
Volatility Over Time: OSAP.Q's weekly volatility has increased from 44% to 82% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 136 | Len Liptak | www.prosomnus.com |
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.
ProSomnus, Inc. Fundamentals Summary
| OSAP.Q fundamental statistics | |
|---|---|
| Market cap | US$236.56k |
| Earnings (TTM) | -US$29.85m |
| Revenue (TTM) | US$31.46m |
0.0x
P/S Ratio0.0x
P/E RatioIs OSAP.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSAP.Q income statement (TTM) | |
|---|---|
| Revenue | US$31.46m |
| Cost of Revenue | US$15.82m |
| Gross Profit | US$15.64m |
| Other Expenses | US$45.49m |
| Earnings | -US$29.85m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.72 |
| Gross Margin | 49.71% |
| Net Profit Margin | -94.88% |
| Debt/Equity Ratio | -0.4% |
How did OSAP.Q perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/08/06 04:22 |
| End of Day Share Price | 2024/08/06 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ProSomnus, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Scott Henry | Alliance Global Partners |
| Alexander Nowak | Craig-Hallum Capital Group LLC |
| Scott Henry | Roth Capital Partners |